Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

BUY
$1.13 - $3.69 $565 - $1,845
500 New
500 $1,000
Q1 2022

May 11, 2022

SELL
$2.85 - $3.73 $1,425 - $1,865
-500 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$3.94 - $5.84 $5,122 - $7,592
-1,300 Reduced 72.22%
500 $3,000
Q4 2020

Feb 05, 2021

BUY
$4.04 - $5.31 $7,272 - $9,558
1,800 New
1,800 $9,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $254M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Financial Avengers, Inc. Portfolio

Follow Financial Avengers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Avengers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Avengers, Inc. with notifications on news.